AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.82
+0.35 (3.34%)
Jul 24, 2026, 12:49 PM EDT - Market open

AdaptHealth Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, AdaptHealth stock has a consensus rating of "Strong Buy" and an average price target of $14.14. The average 1-year stock price forecast is 30.68% higher than the current stock price, while the lowest is $12 (+10.91%) and the highest is $16 (+47.87%).

Price Target: $14.14 (+30.68%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$12$14.14$14$16
Change+10.91%+30.68%+29.39%+47.87%

Analyst Ratings

The average analyst rating for AdaptHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy555555
Buy111111
Hold222221
Sell000000
Strong Sell000000
Total888887

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Robert W. Baird
Robert W. Baird
Buy
Maintains
$18$15
BuyMaintains$18$15+38.63%Jul 6, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$16
BuyMaintains$16+47.87%Jul 1, 2026
Truist Financial
Truist Financial
Buy
Reiterates
$14
BuyReiterates$14+29.39%Jun 24, 2026
RBC Capital
RBC Capital
Buy
Maintains
$13$15
BuyMaintains$13$15+38.63%May 8, 2026
UBS
UBS
Buy
Maintains
$15$14
BuyMaintains$15$14+29.39%May 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.49B
from 3.24B
Increased by 7.42%
Revenue Next Year
3.72B
from 3.49B
Increased by 6.61%
EPS This Year
0.89
from 0.54
Increased by 64.33%
EPS Next Year
1.17
from 0.89
Increased by 30.72%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.47B2.97B3.20B3.26B3.24B3.49B
Revenue Growth
130.24%20.51%7.73%1.90%-0.49%7.42%
Gross Profit
524.54M634.32M681.77M749.16M677.93M759.83M
Gross Margin
21.28%21.35%21.30%22.97%20.89%21.80%
Operating Income
225.61M216.11M278.53M288.25M204.57M263.02M
Net Income
156.18M69.32M-678.90M90.42M-70.79M107.22M
EPS
----0.540.89
EPS Growth
-----44.55%64.33%
Forward PE
15.3615.299.869.9111.6012.13
Free Cash Flow
-43.97M2.37M187.78M166.32M246.52M178.29M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.5B
Avg3.5B
Low3.4B

Revenue Growth

Revenue Growth202620272028
High
8.0%
Avg
7.4%
Low
6.3%

EPS Forecast

EPS202620272028
High1.11
Avg0.89
Low0.69

EPS Growth

EPS Growth202620272028
High
104.5%
Avg
64.3%
Low
27.1%